Some months ago, Sandra Gallina, the Italian bureaucrat in charge of buying coronavirus vaccines for the EU, appeared in front of the European parliament, invited by MEPs clamouring for greater transparency on the bloc’s confidential procurement contracts with drug developers. “I fully take o
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp